Page last updated: 2024-08-16

tibolone and Breast Neoplasms

tibolone has been researched along with Breast Neoplasms in 90 studies

Research

Studies (90)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	5 (5.56)	18.2507
2000's	61 (67.78)	29.6817
2010's	22 (24.44)	24.3611
2020's	2 (2.22)	2.80

Authors

Authors	Studies
Capozzi, A; Franceschini, G; Lello, S; Scambia, G	1
Fait, T	1
Coupland, C; Hippisley-Cox, J; Vinogradova, Y	1
Ameye, L; Antoine, C; de Azambuja, E; Paesmans, M; Rozenberg, S	2
Graff-Iversen, S; Hofvind, S; Román, M; Sakshaug, S; Ursin, G; Vangen, S; Weiderpass, E	1
Briarava, M; Mocellin, S; Nitti, D; Pilati, P	1
Aragonés, N; Ederra, M; Isidoro, B; Lope, V; Moreo, P; Pedraz, C; Pérez-Gómez, B; Pollán, M; Salas-Trejo, D; Sánchez-Contador, C; Santamariña, C; Vidal, C; Whelan, D	1
Balduzzi, S; Basevi, V; Bassi, C; D'Amico, R; Formoso, G; Maestri, E; Magrini, N; Maltoni, S; Marata, AM; Perrone, E; Wilkinson, J	1
Brinkhuis, M; Franke, HR; Jansen, GH; Vermes, I; Wolbers, F	1
Bilezikian, J; Christiansen, C; Cummings, SR; Delmas, PD; Eastell, R; Ettinger, B; Grobbee, DE; Johnson, S; Kenemans, P; Kerzberg, EM; Kloosterboer, L; Mol-Arts, M; Mosca, L; Seifert, W; Stathopoulos, V; Verweij, P; Zanchetta, J	1
Bentolila, J; Boisserie-Lacroix, M; Bouzgarrou, M; Cavagni, P; Laumonier, H; Lebiez-Michel, N; Trillaud, H	1
Chlebowski, RT; Prentice, R	1
Beckmann, MW; Bundred, NJ; Egberts, J; Foidart, JM; Kenemans, P; Kubista, E; Mol-Arts, M; Mulder, R; Sismondi, P; van Os, S; Vassilopoulou-Sellin, R; von Schoultz, B; Yip, CH	1
Goodwin, PJ	1
Agorastos, T; Bontis, JN; Goulis, DG; Pantazis, K; Vavilis, D; Zafrakas, M	1
Speroff, L	2
Courtin, A; Forgez, P; Gompel, A; Kloosterboer, HJ; Petit, E; Rostène, W	1
Fu, R; Griffin, JC; Humphrey, L; Nelson, HD; Nygren, P; Smith, ME	1
de Melo, NR; Pompei, LM	1
Kenemans, P	1
Bonfill, X; Martínez-Pino, I; Puig, T; Quintana, MJ; Solà, J	1
Antsaklis, A; Dimitrakakis, C; Keramopoulos, D; Tsigginou, A	1
Baber, R; Huang, KE	1
Biglia, N; Lello, S; Maffei, S; Nappi, RE	1
Lyytinen, H; Ylikorkala, O	1
Arun, B; Brown, PH; Castiglione, M; Cuzick, J; DeCensi, A; Dunn, B; Forbes, JF; Glaus, A; Howell, A; Vogel, V; von Minckwitz, G; Zwierzina, H	1
De Geyter, C; De Napoli, G; de Weerd, V; Foekens, JA; Kloosterboer, HJ; Martens, JW; Sieuwerts, AM; van Galen, A; Zhang, H	1
Biglia, N; Egberts, J; Kenemans, P; Kimmig, R; Kubista, E; Moggio, G; Mol-Arts, M; Mulder, R; Planellas, J; Sismondi, P	1
Beckmann, MW; Bundred, NJ; Foidart, JM; Galta, RE; Kenemans, P; Kubista, E; Lieshout, EV; Mol-Arts, M; Planellas, J; Schoultz, Bv; Sismondi, P; Vassilopoulou-Sellin, R; Yip, CH	1
Balduzzi, S; Basevi, V; Bassi, C; D'Amico, R; Formoso, G; Maestri, E; Magrini, N; Maltoni, S; Marata, AM; Perrone, E	1
Bakken, K; Lund, E; Sæther, S	1
Eyster, KM; Hansen, KA	1
Bodine, PV; Harris, HA; Komm, BS; Lyttle, CR	1
Blankenstein, MA; Donker, GH; Sprong, M; Thijssen, JH; van de Ven, J	1
Kloosterboer, HJ	1
Lippert, C; Mueck, AO; Seeger, H; Wallwiener, D	2
Davis, SR; Davison, S	1
Metsä-Heikkilä, M; Ylikorkala, O	1
Crosignani, PG	1
Gambacciani, M; Genazzani, AR	1
Bundred, NJ; Morris, J	1
Helmond, FA	1
Neves-E-Castro, M	1
Kelly, MW; Swegle, JM	1
Başaran, E; Başaran, T; Fiçicioğlu, C; Kutlu, T; Topaloğlu, T	1
Bundred, NJ; Turner, LE	1
Boerstoel-Streefland, M; Hendricks, PT; Wierik, EJ	1
Bundred, N; Fentiman, IS; Foidart, JM; Helmond, FA; Kroiss, R; Kubista, E; Mol-Arts, M; Rymer, J	1
Boisserie-Lacroix, M; Boutet, G; Trillaud, H	1
Anderson, GL; Chlebowski, RT	1
Chetrite, GS; Pasqualini, JR	1
Bazzocchi, M; Della Martina, M; Driul, L; Fabiani, G; Ianni, A; Marchesoni, D; Zuiani, C	1
Archer, DF; Mirkin, S; Wong, BC	2
Eden, J	1
Eden, J; Genazzani, A; Hendrix, S; Pike, M; Santen, R; Yaffe, M	1
Carvajal, A; Kato, S; Monso, C; Owen, GI; Pinto, M; Sadarangani, A; Salgado, AM; Vigil, P	1
Baber, R; Hickey, M; Kwik, M	1
Farmer, R	1
Franke, HR; Vermes, I; Werner, HM	1
Bredakis, N; Dimitrakakis, C; Gaki, V; Keramopoulos, A; Keramopoulos, D; Vourli, G	1
Bailey, S; Banks, E; Barrett, N; Beral, V; Briers, P; Bull, D; Crossley, B; English, R; Hilton, E; Jackson, A; Kutt, E; Lavelle, J; Patnick, J; Reeves, G; Rockall, L; Simmonds, M; Wallis, MG; Wilson, M	1
Bourg, F; Jamin, C; Legeai, J; Senoussi, S	1
Bracke, ME; Depypere, HT; Kloosterboer, HJ; Vanhoecke, BW	1
Erel, CT; Kaleli, S; Senturk, LM	1
Kimmig, R; Schmidt, M	1
Agorastos, T; Bontis, JN; Goulis, DG; Goutzioulis, A; Goutzioulis, M; Konstantinidis, T; Makedos, G; Pantazis, K; Vavilis, D	1
Antoine, C; Carly, B; Liebens, F; Pastijn, A; Rozenberg, S	1
Gompel, A; Piette, JC	1
Götte, M; Kiesel, L; Stute, P	1
Dowsett, M; Foidart, JM; Hageluken, CC; Kubista, E; Manikhas, AG; Nechushkin, M; Planellas Gomez, JV; Pohlodek, K; Semiglazov, VF; Serreyn, R; Singer, CF	1
Kloosterboer, HJ; Löfgren, L; Verheul, HA; von Schoultz, B; von Schoulz, E	1
Chao, HT; Chao, KC; Cheng, MH; Wang, PH	1
Beckmann, MW; Bundred, NJ; Egberts, J; Foidart, JM; Kenemans, P; Kubista, E; Planellas, J; Sismondi, P; van Os, S; Vassilopoulou-Sellin, R; von Schoultz, B; Yip, CH	1
Assouline, S; Dell'Aniello, S; Opatrny, L; Suissa, S	1
Lazovic, G; Marinkovic, J; Radivojevic, U	1
Coomarasamy, A	1
Montes, A; O'Brien, M; Powles, TJ	1
de Chambine, S; Decroix, Y; Gompel, A; Jacob, D; Mimoun, M; Poitout, P; Rostene, W	1
Christiansen, C	1
Brouillet, JP; Maudelonde, T; Pujol, P	1
Moore, RA	1
Gompel, A; Kloosterboer, HJ; Lombet, A; Rostène, W; Siromachkova, M	1
Birkhäuser, MH	1
Hooymans, C; Malini, B; Newman, SP; Purohit, A	1

Reviews

28 review(s) available for tibolone and Breast Neoplasms

Article	Year
Tibolone and Breast Tissue: a Review. Reproductive sciences (Thousand Oaks, Calif.), 2023, Volume: 30, Issue:12 Topics: Breast Neoplasms; Estrogen Receptor Modulators; Female; Hormone Replacement Therapy; Humans; Norpregnenes	2023
Breast Cancer Chemoprevention: A Network Meta-Analysis of Randomized Controlled Trials. Journal of the National Cancer Institute, 2016, Volume: 108, Issue:2 Topics: Adult; Aged; Anticarcinogenic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Middle Aged; Norpregnenes; Piperidines; Postmenopause; Primary Prevention; Pyrrolidines; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk Assessment; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Thiophenes	2016
Short-term and long-term effects of tibolone in postmenopausal women. The Cochrane database of systematic reviews, 2016, Oct-12, Volume: 10 Topics: Aged; Breast Neoplasms; Dyspareunia; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Neoplasm Recurrence, Local; Norpregnenes; Postmenopause; Randomized Controlled Trials as Topic; Stroke; Sweating; Uterine Hemorrhage	2016
[Hormones and mammographic breast density]. Journal de radiologie, 2008, Volume: 89, Issue:9 Pt 2 Topics: Adult; Aged; Biopsy; Breast; Breast Neoplasms; Contraceptive Agents, Female; Diagnosis, Differential; Estrogen Replacement Therapy; Female; Gonadal Steroid Hormones; Hormones; Humans; Intrauterine Devices; Levonorgestrel; Mammography; Menopause; Menstrual Cycle; Middle Aged; Norpregnenes; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Selective Estrogen Receptor Modulators; Sensitivity and Specificity; Tamoxifen	2008
Systematic review: comparative effectiveness of medications to reduce risk for primary breast cancer. Annals of internal medicine, 2009, Nov-17, Volume: 151, Issue:10 Topics: Breast Neoplasms; Endometrial Neoplasms; Estrogen Receptor Modulators; Female; Fractures, Bone; Humans; Norpregnenes; Raloxifene Hydrochloride; Stroke; Tamoxifen; Thromboembolism	2009
Updated clinical recommendations for the use of tibolone in Asian women. Climacteric : the journal of the International Menopause Society, 2010, Volume: 13, Issue:4 Topics: Arthralgia; Breast Neoplasms; Cardiovascular Diseases; Contraindications; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Health Knowledge, Attitudes, Practice; Hot Flashes; Humans; Middle Aged; Musculoskeletal Diseases; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Rural Population; Sexual Dysfunctions, Psychological; Sleep Initiation and Maintenance Disorders; Urban Population	2010
Tibolone in postmenopausal women: a review based on recent randomised controlled clinical trials. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2010, Volume: 26, Issue:11 Topics: Breast Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Myocardial Infarction; Norpregnenes; Postmenopause; Quality of Life; Randomized Controlled Trials as Topic; Recurrence; Thromboembolism	2010
Preventive therapy for breast cancer: a consensus statement. The Lancet. Oncology, 2011, Volume: 12, Issue:5 Topics: Anastrozole; Androstadienes; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Consensus Development Conferences as Topic; Diphosphonates; Estrogen Receptor Modulators; Expert Testimony; Female; Fenretinide; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Metformin; Nitriles; Norpregnenes; Piperidines; Premenopause; Pyrrolidines; Raloxifene Hydrochloride; Retinoids; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Thiophenes; Triazoles	2011
Short and long term effects of tibolone in postmenopausal women. The Cochrane database of systematic reviews, 2012, Feb-15, Issue:2 Topics: Aged; Breast Neoplasms; Dyspareunia; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Neoplasm Recurrence, Local; Norpregnenes; Postmenopause; Stroke; Sweating; Uterine Hemorrhage	2012
Hormone replacement therapy: current controversies. Clinical endocrinology, 2003, Volume: 58, Issue:3 Topics: Aged; Androgens; Breast Neoplasms; Cardiovascular Diseases; Cognition Disorders; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Humans; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Patient Selection; Phytotherapy; Postmenopause; Progestins; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Thrombosis	2003
Hormone replacement therapy in women with a history of breast cancer. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2002, Volume: 16, Issue:6 Topics: Breast Neoplasms; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Menopause; Neoplasm Recurrence, Local; Norpregnenes; Quality of Life; Risk Factors; Selective Estrogen Receptor Modulators	2002
The Million Women Study and breast cancer. Maturitas, 2003, Sep-25, Volume: 46, Issue:1 Topics: Breast Neoplasms; Cohort Studies; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Mammography; Middle Aged; Norpregnenes; Postmenopause; Risk Factors; United Kingdom; Women's Health	2003
Tibolone: a unique version of hormone replacement therapy. The Annals of pharmacotherapy, 2004, Volume: 38, Issue:5 Topics: Breast Neoplasms; Cardiovascular System; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Menopause; Norpregnenes; Osteoporosis, Postmenopausal; Thromboembolism	2004
Postmenopausal hormone therapy before and after breast cancer: clinical experiences. Maturitas, 2004, Sep-24, Volume: 49, Issue:1 Topics: Breast Neoplasms; Female; Hormone Replacement Therapy; Humans; Neoplasm Recurrence, Local; Norpregnenes; Postmenopause; Selective Estrogen Receptor Modulators	2004
[Menopausal hormonal therapies: impact on mammographic breast density]. Journal de radiologie, 2004, Volume: 85, Issue:10 Pt 1 Topics: Breast; Breast Neoplasms; Estrogen Receptor Modulators; Female; Hormone Replacement Therapy; Humans; Mammography; Mass Screening; Menopause; Norpregnenes; Raloxifene Hydrochloride	2004
Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer. The Journal of steroid biochemistry and molecular biology, 2005, Volume: 93, Issue:2-5 Topics: 17-Hydroxysteroid Dehydrogenases; Biotransformation; Breast; Breast Neoplasms; Cell Line, Tumor; Enzyme Inhibitors; Estrogen Antagonists; Estrogens; Female; Humans; Neoplasms, Hormone-Dependent; Norpregnenes; Progesterone Congeners; Receptors, Estrogen; RNA, Messenger; RNA, Neoplasm; Sulfatases	2005
The need for tissue selective menopausal agents. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2005, Volume: 21 Suppl 1 Topics: Breast; Breast Neoplasms; Estrogen Replacement Therapy; Female; Humans; Mammography; Norpregnenes; Postmenopause; Selective Estrogen Receptor Modulators	2005
Therapy for menopausal symptoms during and after treatment for breast cancer : safety considerations. Drug safety, 2005, Volume: 28, Issue:12 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Case-Control Studies; Clonidine; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Health Behavior; Hot Flashes; Humans; Menopause; Norpregnenes; Paroxetine; Personal Health Services; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Tamoxifen	2005
Tibolone and breast cancer. Postgraduate medical journal, 2006, Volume: 82, Issue:972 Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Humans; Macaca fascicularis; Norpregnenes; Radiography; Rats	2006
[The benefits and risks of hormonal replacement therapy--an update]. Gynakologisch-geburtshilfliche Rundschau, 2006, Volume: 46, Issue:4 Topics: Adult; Age Factors; Aged; Breast Neoplasms; Cardiovascular Diseases; Colonic Neoplasms; Dementia; Endometrial Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Follow-Up Studies; Humans; Meta-Analysis as Topic; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Ovarian Neoplasms; Primary Prevention; Progestins; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Risk Factors; Stroke; Thromboembolism; Time Factors	2006
Safety of alternative treatments for menopausal symptoms after breast cancer: a qualitative systematic review. Climacteric : the journal of the International Menopause Society, 2007, Volume: 10, Issue:1 Topics: Antidepressive Agents; Breast Neoplasms; Estrogen Receptor Modulators; Female; Histamine H1 Antagonists; Hot Flashes; Humans; Menopause; Norpregnenes	2007
Systemic lupus erythematosus and hormone replacement therapy. Menopause international, 2007, Volume: 13, Issue:2 Topics: Animals; Breast Neoplasms; Contraindications; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Lupus Coagulation Inhibitor; Lupus Erythematosus, Systemic; Norpregnenes; Osteoporosis, Postmenopausal; Progesterone; Progestins; Research Design; Risk Assessment; Thrombosis; Women's Health	2007
Effects of tibolone on the breast of postmenopausal women. Taiwanese journal of obstetrics & gynecology, 2007, Volume: 46, Issue:2 Topics: Breast; Breast Neoplasms; Estrogen Receptor Modulators; Female; Hormone Replacement Therapy; Humans; Mammography; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause	2007
Tibolone: the way to beat many a postmenopausal ailments. Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:6 Topics: Breast Neoplasms; Cardiovascular Diseases; Climacteric; Endometrium; Estrogen Receptor Modulators; Estrogens; Female; Hot Flashes; Humans; Menopause; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause; Randomized Controlled Trials as Topic; Risk Factors; Stroke	2008
[Action of SERM and SAS (tibolone) on breast tissue]. Contraception, fertilite, sexualite (1992), 1999, Volume: 27, Issue:5 Topics: Antineoplastic Agents, Hormonal; Breast; Breast Neoplasms; Estrogen Antagonists; Female; Humans; Neoplasms, Hormone-Dependent; Norpregnenes; Receptors, Estrogen; Tamoxifen	1999
[Anti-estrogens, selective estrogen receptor modulators (SERM), tibolone: modes of action]. Contraception, fertilite, sexualite (1992), 1999, Volume: 27, Issue:9 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Estrogen Receptor Modulators; Female; Humans; Norpregnenes; Selective Estrogen Receptor Modulators; Tamoxifen	1999
Livial: a review of clinical studies. British journal of obstetrics and gynaecology, 1999, Volume: 106 Suppl 19 Topics: Affective Symptoms; Anabolic Agents; Bone Diseases; Breast Neoplasms; Climacteric; Coronary Disease; Endometriosis; Estrogen Replacement Therapy; Female; Humans; Libido; Norpregnenes; Postmenopause; Randomized Controlled Trials as Topic; Uterine Hemorrhage; Vaginal Diseases	1999
[Indications for hormone replacement therapy]. Therapeutische Umschau. Revue therapeutique, 2000, Volume: 57, Issue:10 Topics: Aged; Alzheimer Disease; Anabolic Agents; Breast Neoplasms; Cardiovascular Diseases; Contraindications; Endometrial Neoplasms; Estrogen Replacement Therapy; Estrogens; Female; Humans; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause; Progestins; Raloxifene Hydrochloride; Risk; Selective Estrogen Receptor Modulators; Thrombosis	2000

Trials

14 trial(s) available for tibolone and Breast Neoplasms

Article	Year
Menopausal hormone therapy use in 17 European countries during the last decade. Maturitas, 2014, Volume: 79, Issue:3 Topics: Aged; Breast Neoplasms; Coronary Disease; Estrogen Replacement Therapy; Estrogens; Europe; Female; Global Health; Humans; Menopause; Middle Aged; Norpregnenes; Progestins; Pulmonary Embolism; Risk Factors; Stroke	2014
The effects of tibolone in older postmenopausal women. The New England journal of medicine, 2008, Aug-14, Volume: 359, Issue:7 Topics: Aged; Aged, 80 and over; Androgen Antagonists; Bone Density; Breast Neoplasms; Colonic Neoplasms; Double-Blind Method; Endometrial Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause; Radiography; Risk; Spinal Fractures; Stroke	2008
Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial. The Lancet. Oncology, 2009, Volume: 10, Issue:2 Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Double-Blind Method; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Neoplasm Recurrence, Local; Norpregnenes; Osteoporosis, Postmenopausal; Vasomotor System	2009
What have we really learned from 'LIBERATE' trial? Maturitas, 2010, Volume: 66, Issue:1 Topics: Breast Neoplasms; Estrogen Receptor Modulators; Female; Hot Flashes; Humans; Menopause; Neoplasm Recurrence, Local; Norpregnenes	2010
Hormone replacement therapy dependent changes in breast cancer-related gene expression in breast tissue of healthy postmenopausal women. Molecular oncology, 2011, Volume: 5, Issue:6 Topics: Breast; Breast Neoplasms; Estradiol; Estrogen Receptor Modulators; Female; Gene Expression Regulation, Neoplastic; Hormone Replacement Therapy; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Prospective Studies; Risk Factors	2011
Effects of tibolone on climacteric symptoms and quality of life in breast cancer patients--data from LIBERATE trial. Maturitas, 2011, Volume: 70, Issue:4 Topics: Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Atrophic Vaginitis; Breast Neoplasms; Climacteric; Contraindications; Estrogen Receptor Modulators; Female; Hot Flashes; Humans; Intention to Treat Analysis; Longitudinal Studies; Middle Aged; Norpregnenes; Postmenopause; Quality of Life; Surveys and Questionnaires; Tamoxifen	2011
Tibolone increases bone mineral density but also relapse in breast cancer survivors: LIBERATE trial bone substudy. Breast cancer research : BCR, 2012, Jan-17, Volume: 14, Issue:1 Topics: Adult; Aged; Analysis of Variance; Body Mass Index; Bone Density; Bone Density Conservation Agents; Breast Neoplasms; Double-Blind Method; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Norpregnenes; Osteoporosis; Selective Estrogen Receptor Modulators; Survivors	2012
The effect of tibolone in postmenopausal women receiving tamoxifen after surgery for breast cancer: a randomised, double-blind, placebo-controlled trial. BJOG : an international journal of obstetrics and gynaecology, 2005, Volume: 112, Issue:2 Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Chemotherapy, Adjuvant; Double-Blind Method; Endometrium; Estrogen Antagonists; Estrogen Receptor Modulators; Female; Hot Flashes; Humans; Hyperhidrosis; Lipids; Mammography; Middle Aged; Neoplasm Recurrence, Local; Norpregnenes; Pilot Projects; Postmenopause; Tamoxifen	2005
Postmenopausal hormone therapy and mammographic breast density. Maturitas, 2006, Jan-10, Volume: 53, Issue:1 Topics: Breast; Breast Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Mammography; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Prospective Studies; Single-Blind Method; Treatment Outcome	2006
Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer. Climacteric : the journal of the International Menopause Society, 2005, Volume: 8, Issue:4 Topics: Adult; Aged; Breast Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Mammography; Middle Aged; Neoplasm Recurrence, Local; Norpregnenes; Postmenopause; Prospective Studies; Tamoxifen	2005
Effect of tibolone on breast cancer cell proliferation in postmenopausal ER+ patients: results from STEM trial. Clinical cancer research : an official journal of the American Association for Cancer Research, 2007, Jul-15, Volume: 13, Issue:14 Topics: Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Division; Combined Modality Therapy; Female; Humans; Middle Aged; Norpregnenes; Placebos; Postmenopause; Safety	2007
Estrogen and tibolone metabolite levels in blood and breast tissue of postmenopausal women recently diagnosed with early-stage breast cancer and treated with tibolone or placebo for 14 days. Reproductive sciences (Thousand Oaks, Calif.), 2007, Volume: 14, Issue:2 Topics: Aged; Androstenols; Breast; Breast Neoplasms; Chromatography, Liquid; Double-Blind Method; Estradiol; Estrenes; Estrone; Female; Gas Chromatography-Mass Spectrometry; Humans; Middle Aged; Neoplasm Staging; Norpregnenes; Postmenopause; Selective Estrogen Receptor Modulators; Tandem Mass Spectrometry; Tissue Distribution	2007
Safety of tibolone in the treatment of vasomotor symptoms in breast cancer patients--design and baseline data 'LIBERATE' trial. Breast (Edinburgh, Scotland), 2007, Volume: 16 Suppl 2 Topics: Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Autonomic Nervous System Diseases; Bone Density; Breast Neoplasms; Double-Blind Method; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Norpregnenes; Quality of Life; Survival Analysis; Tamoxifen; Treatment Outcome; Vasomotor System	2007
Hormone replacement therapy as treatment of breast cancer--a phase II study of Org OD 14 (tibilone). British journal of cancer, 1996, Volume: 73, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Breast Neoplasms; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Norpregnenes; Patient Compliance; Poisson Distribution; Receptors, Estrogen	1996

Other Studies

48 other study(ies) available for tibolone and Breast Neoplasms

Article	Year
Tibolon - the only one member of STEARs group. Casopis lekaru ceskych, 2019,Summer, Volume: 158, Issue:3-4 Topics: Breast Neoplasms; Climate; Estrogen Receptor Modulators; Estrogens; Female; Humans; Menopause; Norpregnenes; Osteoporosis; Progestins	2019
Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases. BMJ (Clinical research ed.), 2020, 10-28, Volume: 371 Topics: Aged; Breast Neoplasms; Case-Control Studies; Databases, Factual; Estrogens; Female; Hormone Replacement Therapy; Humans; Incidence; Middle Aged; Norpregnenes; Progestins; Risk Assessment	2020
Postmenopausal hormone therapy and the risk of breast cancer in Norway. International journal of cancer, 2016, Feb-01, Volume: 138, Issue:3 Topics: Aged; Breast Neoplasms; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Humans; Middle Aged; Norethindrone; Norpregnenes; Risk	2016
Menopausal hormone therapy use in relation to breast cancer incidence in 11 European countries. Maturitas, 2016, Volume: 84 Topics: Aged; Breast Neoplasms; Commerce; Databases, Pharmaceutical; Estrogen Receptor Modulators; Europe; Female; Hormone Replacement Therapy; Humans; Incidence; Menopause; Middle Aged; Norpregnenes	2016
Use of hormone therapy and isoflavones and mammographic density in Spain. Menopause (New York, N.Y.), 2016, Volume: 23, Issue:5 Topics: Aged; Breast Density; Breast Neoplasms; Cross-Sectional Studies; Early Detection of Cancer; Estrogen Replacement Therapy; Estrogens; Female; Humans; Isoflavones; Mammography; Middle Aged; Norpregnenes; Postmenopause; Spain	2016
Effects of fulvestrant alone or combined with different steroids in human breast cancer cells in vitro. Climacteric : the journal of the International Menopause Society, 2008, Volume: 11, Issue:4 Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Dydrogesterone; Estradiol; Estrogen Antagonists; Estrogen Receptor Modulators; Estrogens; Female; Fulvestrant; Hormone Replacement Therapy; Humans; In Vitro Techniques; Norpregnenes; Progestins; Receptors, Estrogen; RNA, Messenger	2008
Tibolone in older postmenopausal women. The New England journal of medicine, 2008, Nov-13, Volume: 359, Issue:20 Topics: Androgen Antagonists; Breast Neoplasms; Diagnostic Errors; Estrogen Replacement Therapy; Female; Fractures, Bone; Humans; Mammography; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause; Risk	2008
Tibolone: the risk is too high. The Lancet. Oncology, 2009, Volume: 10, Issue:2 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Clinical Trials as Topic; Estrogen Replacement Therapy; Hot Flashes; Humans; Menopause; Neoplasm Recurrence, Local; Norpregnenes; Risk	2009
Hormone therapy for postmenopausal breast cancer survivors: a survey among obstetrician-gynaecologists. European journal of gynaecological oncology, 2009, Volume: 30, Issue:1 Topics: Breast Neoplasms; Data Collection; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Greece; Gynecology; Hot Flashes; Humans; Norpregnenes; Osteoporosis, Postmenopausal; Practice Patterns, Physicians'	2009
The LIBERATE tibolone trial in breast cancer survivors. Maturitas, 2009, May-20, Volume: 63, Issue:1 Topics: Breast Neoplasms; Contraindications; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Norpregnenes; Postmenopause; Randomized Controlled Trials as Topic; Survivors	2009
Progestins induce catalase activities in breast cancer cells through PRB isoform: correlation with cell growth inhibition. The Journal of steroid biochemistry and molecular biology, 2009, Volume: 115, Issue:3-5 Topics: Breast; Breast Neoplasms; Catalase; Cell Line, Tumor; Estrogen Receptor Modulators; Female; Humans; Hydrogen Peroxide; Norpregnenes; Oxidants; Progesterone; Progestins; Reactive Oxygen Species; Receptors, Progesterone	2009
Tibolone reduces osteoporotic fracture risk and breast cancer risk, but increases the risk of stroke. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2010, Volume: 26, Issue:2 Topics: Aged; Aged, 80 and over; Breast Neoplasms; Estrogen Receptor Modulators; Female; Humans; Middle Aged; Norpregnenes; Osteoporotic Fractures; Stroke	2010
Tibolone revisited: still a good treatment option for healthy, early postmenopausal women. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2010, Volume: 26, Issue:4 Topics: Age Factors; Breast Neoplasms; Contraindications; Estrogen Receptor Modulators; Female; Heart Diseases; Hot Flashes; Humans; Norpregnenes; Patient Selection; Postmenopause; Risk Factors; Stroke	2010
[Prevalence of use of hormone replacement therapy in women participating in a breast cancer screening program]. Medicina clinica, 2010, Apr-10, Volume: 134, Issue:10 Topics: Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Confidence Intervals; Data Interpretation, Statistical; Estrogen Replacement Therapy; Estrogens; Female; Health Surveys; Hormone Replacement Therapy; Humans; Mass Screening; Menopause; Middle Aged; Norpregnenes; Postmenopause; Prevalence; Progestins; Socioeconomic Factors; Spain; Surveys and Questionnaires	2010
Tibolone and breast cancer. Prescrire international, 2010, Volume: 19, Issue:111 Topics: Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Menopause; Middle Aged; Norpregnenes	2010
[Hormone therapy and risk for breast cancer in Finnish postmenopausal women]. Duodecim; laaketieteellinen aikakauskirja, 2011, Volume: 127, Issue:3 Topics: Aged; Breast Neoplasms; Contraceptive Agents, Female; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Finland; Humans; Intrauterine Devices; Levonorgestrel; Middle Aged; Norpregnenes; Postmenopause; Risk Factors	2011
The risk of breast cancer linked to menopausal hormone therapy. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2012, Jun-12, Volume: 132, Issue:11 Topics: Breast Neoplasms; Case-Control Studies; Drug Therapy, Combination; Estradiol; Estriol; Estrogen Receptor Modulators; Female; Hormone Replacement Therapy; Humans; Middle Aged; Norpregnenes; Odds Ratio; Postmenopause; Progestins; Prospective Studies; Risk Factors; Surveys and Questionnaires	2012
What happened to WHI: menopausal hormonal therapy in 2012. Clinical obstetrics and gynecology, 2012, Volume: 55, Issue:3 Topics: Atrophy; Breast Neoplasms; Endometrial Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Hot Flashes; Humans; Menopause; Middle Aged; Norpregnenes; Patient Selection; Raloxifene Hydrochloride; Vagina	2012
Estrogenic effects of 7alpha-methyl-17alpha-ethynylestradiol: a newly discovered tibolone metabolite. Steroids, 2002, Volume: 67, Issue:8 Topics: Animals; Breast Neoplasms; Cell Division; Estradiol; Ethinyl Estradiol; Female; Gene Expression Regulation; Genes, Reporter; In Vitro Techniques; Inhibitory Concentration 50; Molecular Structure; Norpregnenes; Organ Size; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Response Elements; Tumor Cells, Cultured; Uterus	2002
Effect of tibolone (Org OD14) and its metabolites on aromatase and estrone sulfatase activity in human breast adipose stromal cells and in MCF-7 and T47D breast cancer cells. The Journal of steroid biochemistry and molecular biology, 2002, Volume: 81, Issue:3 Topics: 17-Hydroxysteroid Dehydrogenases; Adipose Tissue; Aromatase; Breast; Breast Neoplasms; Dose-Response Relationship, Drug; Estradiol; Estrogen Receptor Modulators; Estrogens; Humans; Immunohistochemistry; Ligands; Models, Chemical; Norpregnenes; Protein Binding; Receptors, Progesterone; Stromal Cells; Sulfatases; Tumor Cells, Cultured	2002
Endocrine prevention of breast: any role for tibolone? European journal of cancer (Oxford, England : 1990), 2002, Volume: 38 Suppl 6 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinogens; Female; Humans; Neoplasm Transplantation; Norpregnenes; Rats	2002
Effects of tibolone on human breast cancer cells and human vascular coronary cells. Archives of gynecology and obstetrics, 2003, Volume: 267, Issue:3 Topics: Breast Neoplasms; Cell Division; Coronary Vessels; E-Selectin; Endothelins; Endothelium, Vascular; Estradiol; Female; Humans; Matrix Metalloproteinase 1; Muscle, Smooth, Vascular; Norpregnenes; Plasminogen Activator Inhibitor 1; Tumor Cells, Cultured	2003
Breast cancer and hormone-replacement therapy in the Million Women Study. Maturitas, 2003, Oct-20, Volume: 46, Issue:2 Topics: Body Mass Index; Breast Neoplasms; Estrogen Replacement Therapy; Estrogens; Female; Humans; Incidence; Middle Aged; Norpregnenes; Progestins; Risk Factors; Time Factors	2003
The sound of an International anti-HRT herald. Maturitas, 2003, Oct-20, Volume: 46, Issue:2 Topics: Breast Neoplasms; Estrogen Replacement Therapy; Estrogens; Female; Humans; Norpregnenes; Progestins; Risk Factors; Surveys and Questionnaires	2003
Breast cancer and hormone-replacement therapy: the Million Women Study. Lancet (London, England), 2003, Oct-18, Volume: 362, Issue:9392 Topics: Breast Neoplasms; Cohort Studies; Drug Combinations; Estrogen Receptor Modulators; Estrogens; Female; Hormone Replacement Therapy; Humans; Incidence; Norpregnenes; Progestins; Risk Factors	2003
Breast cancer and hormone-replacement therapy: the Million Women Study. Lancet (London, England), 2003, Oct-18, Volume: 362, Issue:9392 Topics: Body Mass Index; Breast Neoplasms; Estrogens; Female; Hormone Replacement Therapy; Humans; Incidence; Norpregnenes; Progestins; Research Design	2003
Some comments on the Million Women Study. Climacteric : the journal of the International Menopause Society, 2003, Volume: 6, Issue:4 Topics: Breast Neoplasms; England; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Humans; Incidence; Norpregnenes; Progestins	2003
Mammographic breast density changes after 1 year of tibolone use. Maturitas, 2004, Jun-15, Volume: 48, Issue:2 Topics: Breast; Breast Neoplasms; Drug Administration Schedule; Estrogen Receptor Modulators; Female; Hormone Replacement Therapy; Humans; Mammography; Middle Aged; Norpregnenes; Prospective Studies	2004
Clinical background of women prescribed tibolone or combined estrogen + progestogen therapies: a UK MediPlus study. Climacteric : the journal of the International Menopause Society, 2004, Volume: 7, Issue:2 Topics: Breast Neoplasms; Drug Administration Schedule; Drug Therapy, Combination; Drug Utilization; Endometrial Neoplasms; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norgestrel; Norpregnenes; Practice Patterns, Physicians'; Registries; Retrospective Studies; Risk Factors; United Kingdom	2004
Progestins and recurrence in breast cancer survivors. Journal of the National Cancer Institute, 2005, Apr-06, Volume: 97, Issue:7 Topics: Breast Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Europe; Female; Hot Flashes; Humans; Menopause; Neoplasm Recurrence, Local; Norpregnenes; Progestins; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Survivors; Treatment Outcome	2005
Effect of 17 beta-estradiol, progesterone, synthetic progestins, tibolone, and tibolone metabolites on vascular endothelial growth factor mRNA in breast cancer cells. Fertility and sterility, 2005, Volume: 84, Issue:2 Topics: Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Estradiol; Female; Humans; Norpregnenes; Progesterone; Progesterone Congeners; Prospective Studies; RNA, Messenger; Vascular Endothelial Growth Factor A	2005
Is mammographic density, as currently measured, a robust surrogate marker for breast cancer? Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2005, Volume: 21 Suppl 1 Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Breast; Breast Neoplasms; Contraindications; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Mammography; Middle Aged; Norpregnenes; Risk Factors; Surveys and Questionnaires	2005
In vivo and in vitro estrogenic and progestagenic actions of Tibolone. Biological research, 2005, Volume: 38, Issue:2-3 Topics: Biomarkers, Tumor; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Endometrial Neoplasms; Endometrium; Estrogen Receptor Modulators; Estrogens; Female; Gene Expression Regulation, Neoplastic; Humans; Norpregnenes; Progestins; Time Factors; Ultrasonography	2005
The Million Women Study--is it believable? Climacteric : the journal of the International Menopause Society, 2005, Volume: 8, Issue:3 Topics: Bias; Breast Neoplasms; Data Interpretation, Statistical; Endometrial Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Mass Media; Norpregnenes; Research Design; United Kingdom	2005
Apoptosis and proliferation in breast cancer cells, cultured in vitro: effects of SERMs. Climacteric : the journal of the International Menopause Society, 2005, Volume: 8, Issue:3 Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Contraceptive Agents, Female; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Humans; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Norpregnenes; Progesterone; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Tumor Cells, Cultured	2005
Hormone replacement therapy and false positive recall in the Million Women Study: patterns of use, hormonal constituents and consistency of effect. Breast cancer research : BCR, 2006, Volume: 8, Issue:1 Topics: Breast Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; False Positive Reactions; Female; Humans; Mammography; Mass Screening; Middle Aged; Norpregnenes; Postmenopause; Progestins; Reproducibility of Results; Risk Factors; Sensitivity and Specificity	2006
[Is the clinical profile of women treated with tibolone similar to that of women receiving a classical estrogen-progestogen therapy? Data from a nationwide survey in France]. Gynecologie, obstetrique & fertilite, 2006, Volume: 34, Issue:3 Topics: Age Factors; Aged; Breast Neoplasms; Endometrial Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; France; Health Surveys; Humans; Middle Aged; Norpregnenes; Postmenopause; Risk Factors; Selection Bias	2006
Tibolone and its metabolites inhibit invasion of human mammary carcinoma cells in vitro. Maturitas, 2006, Jun-20, Volume: 54, Issue:3 Topics: Adenocarcinoma; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Estrogen Receptor Modulators; Female; Humans; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Norpregnenes; Osteoporosis, Postmenopausal	2006
Effects of 17beta-estradiol, progesterone, synthetic progestins, tibolone, and raloxifene on vascular endothelial growth factor and Thrombospondin-1 messenger RNA in breast cancer cells. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2006, Volume: 16 Suppl 2 Topics: Breast Neoplasms; Estradiol; Female; Gene Expression Regulation, Neoplastic; Hormones; Humans; Norpregnenes; Progesterone; Progesterone Congeners; Raloxifene Hydrochloride; RNA, Messenger; Thrombospondin 1; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A	2006
Tibolone therapy in breast cancer survivors: a retrospective study. The journal of obstetrics and gynaecology research, 2007, Volume: 33, Issue:1 Topics: Adult; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal; Case-Control Studies; Disease-Free Survival; Female; Humans; Middle Aged; Norpregnenes; Recurrence; Retrospective Studies; Survivors	2007
Differential effect of hormone therapy on E1S-sulfatase activity in non-malignant and cancerous breast cells in vitro. Breast cancer research and treatment, 2008, Volume: 108, Issue:3 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Line, Tumor; Estradiol; Estrogens; Female; Fluorescent Antibody Technique; Gene Expression; Humans; Immunoblotting; Microscopy, Confocal; Norpregnenes; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Steryl-Sulfatase	2008
Hormone replacement therapy use and variations in the risk of breast cancer. BJOG : an international journal of obstetrics and gynaecology, 2008, Volume: 115, Issue:2 Topics: Administration, Cutaneous; Administration, Oral; Aged; Breast Neoplasms; Case-Control Studies; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Hormone Replacement Therapy; Humans; Middle Aged; Norpregnenes; Odds Ratio; Pregnancy; Progesterone; Progestins; Risk Factors	2008
Tibolone and breast cancer risk: effects of selection bias cannot be eliminated in observational studies. BJOG : an international journal of obstetrics and gynaecology, 2008, Volume: 115, Issue:7 Topics: Breast Neoplasms; Cohort Studies; Estrogen Receptor Modulators; Female; Humans; Norpregnenes; Risk Factors; Selection Bias	2008
Sex steroid analogs. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 1999, Volume: 9 Suppl 2 Topics: Animals; Bone Resorption; Breast Neoplasms; Estrogen Antagonists; Female; Gonadal Steroid Hormones; Hormones; Humans; Norpregnenes; Osteoporosis, Postmenopausal; Pyrrolidines; Raloxifene Hydrochloride; Receptors, Estrogen; Risk; Tamoxifen	1999
Tibolone actions on normal and breast cancer cells. European journal of cancer (Oxford, England : 1990), 2000, Volume: 36 Suppl 4 Topics: Antineoplastic Agents, Hormonal; Apoptosis; Breast; Breast Neoplasms; Cell Division; Female; Humans; Norpregnenes; Tumor Cells, Cultured	2000
Inhibition of oestrone sulphatase activity by tibolone and its metabolites. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2002, Volume: 34, Issue:1 Topics: Breast Neoplasms; Enzyme Inhibitors; Estradiol; Estrogen Receptor Modulators; Estrone; Female; Humans; Inhibitory Concentration 50; Microsomes; Norpregnenes; Placenta; Pregnancy; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Selective Estrogen Receptor Modulators; Sulfatases; Tumor Cells, Cultured	2002
Tibolone versus 17beta-estradiol/norethisterone: effects on the proliferation of human breast cancer cells. European journal of gynaecological oncology, 2002, Volume: 23, Issue:2 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Division; Cell Line; Estradiol; Female; Humans; Norethindrone; Norpregnenes; Progesterone Congeners; Tumor Cells, Cultured	2002
Menopause. HRT: looking for something better. Harvard health letter, 2002, Volume: 27, Issue:7 Topics: Breast Neoplasms; Estrogen Replacement Therapy; Female; Humans; Myocardial Infarction; Norpregnenes; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators	2002